Search alternatives:
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
wt decrease » _ decrease (Expand Search), awd decreased (Expand Search), step decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
wt decrease » _ decrease (Expand Search), awd decreased (Expand Search), step decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
14281
Induction of Nano-lantern-positive cells from <i>hSOX10</i><sup><i>2A-NL/+</i></sup> hiPS cells.
Published 2017“…<p>(A-D) Morphology of cultured cells from <i>hSOX10</i><sup><i>2A-NL/+</i></sup> hiPS cells during 3 days (Day3) to 9 days (Day9). …”
-
14282
Image_1_Evidence of Neutralizing and Non-Neutralizing Anti-Glucosaminidase Antibodies in Patients With S. Aureus Osteomyelitis and Their Association With Clinical Outcome Following...
Published 2022“…Therefore, we first optimized an in vitro assay that quantifies recombinant Gmd lysis of the M. luteus cell wall and used it to demonstrate the 50% neutralizing concentration (NC<sub>50</sub>) of a humanized anti-Gmd mAb (TPH-101) to be ~15.6 μg/ml. …”
-
14283
Image_3_Evidence of Neutralizing and Non-Neutralizing Anti-Glucosaminidase Antibodies in Patients With S. Aureus Osteomyelitis and Their Association With Clinical Outcome Following...
Published 2022“…Therefore, we first optimized an in vitro assay that quantifies recombinant Gmd lysis of the M. luteus cell wall and used it to demonstrate the 50% neutralizing concentration (NC<sub>50</sub>) of a humanized anti-Gmd mAb (TPH-101) to be ~15.6 μg/ml. …”
-
14284
Image_2_Evidence of Neutralizing and Non-Neutralizing Anti-Glucosaminidase Antibodies in Patients With S. Aureus Osteomyelitis and Their Association With Clinical Outcome Following...
Published 2022“…Therefore, we first optimized an in vitro assay that quantifies recombinant Gmd lysis of the M. luteus cell wall and used it to demonstrate the 50% neutralizing concentration (NC<sub>50</sub>) of a humanized anti-Gmd mAb (TPH-101) to be ~15.6 μg/ml. …”
-
14285
DataSheet1_Safety and Efficacy of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases: A Systematic Review and Meta-Analysis.docx
Published 2024“…The random-effects model (when I<sup>2</sup> ≥ 50%) or fixed effect model (I<sup>2</sup> < 50%) was used.…”
-
14286
Combination therapy of high dose PC1, kansui, and JQ1 reactivates latent HIV in a primary CD4+ T cell model of HIV latency.
Published 2018“…At 12 days post infection, cells were stimulated for 24 hours with: (A) PC1 (24 μM) and kansui (50 μg/ml) (B) PC1 (24 μM) and JQ1 (0.1 μM) (C) e PC1 (24 μM), kansui (50 μg/ml), and JQ1 (0.1 μM). …”
-
14287
Combination therapy of low dose PC1, kansui, and JQ1 reactivates latent HIV in a primary CD4+ T cell model of HIV latency.
Published 2018“…At 12 days post infection, cells were stimulated for 24 hours with: (A) single and double PC1 (6 μM) and kansui (50 μg/ml) (B) single and double PC1 (6 μM) and JQ1 (0.1 μM) (C) single and triple PC1 (6 μM), kansui (50 μg/ml), and JQ1 (0.1 μM). …”
-
14288
-
14289
Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine <i>versus</i> the 23-Valent Polysaccharide Vaccine in Unvaccinated HIV-Infected Adults: A Pilot, Prospecti...
Published 2016“…</p><p>Methods</p><p>We performed a pilot, prospective controlled study enrolling HIV-infected pneumococcal vaccine-naïve outpatients, aged 18–65 years with CD4 counts ≥200 cells/μL. …”
-
14290
Refractive Profiles in Children Receiving School-Based Eye Exams Following Vision Screening from a Large School-Based Vision Program in 2016 to 2022
Published 2024“…Main outcomes included any refractive error (at least −0.50D myopia, +0.50 hyperopia, 1.00D astigmatism, or 1.00D anisometropia), clinically significant refractive error (CSRE; more severe refractive error with decreased vision), and refractive amblyopia risk (RAR). …”
-
14291
Ouabain block of the Na<sup>+</sup>/K<sup>+</sup> pump switches Purkinje cell activity out of the trimodal firing pattern and into a continuous burst mode.
Published 2013“…In this case, the only deflections observed are those of the Ca<sup>2+</sup> spikes that have travelled into the soma from the dendritic arborisation (<i>E</i>, <i>I</i>). <i>Panel A scaling is encoded in the first scale bar (50 mV, 50 s). …”
-
14292
-
14293
-
14294
-
14295
-
14296
-
14297
-
14298
-
14299
Figure S1 - Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Neuroblastoma
Published 2013“…In the SK-N-AS xenografts <b>A</b>, there was a significant decrease in tumor volume in the animals that received M002 and 4 doses of XRT versus those that received only one or two doses of XRT with their M002. …”
-
14300